Molecular mechanisms regulating expression and function of transcription regulator "inhibitor of differentiation 3"

Acta Pharmacologica Sinica

Volumn 26, Issue 12, 2005, Pages 1409-1420

  Lim, Robert Wai Sui ^a   Wu, Jin Mei ^b  

^a University of Missouri   (United States)

^b JIANGSU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Gene expression regulation; Inhibitor of differentiation 3 protein; Neoplasm; Transcription factors

Indexed keywords

INHIBITOR OF DIFFERENTIATION 3;

ATHEROGENESIS; CANCER; CELL SPECIFICITY; CELL TYPE; CORRELATION ANALYSIS; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STABILITY; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; STIMULUS RESPONSE;

ALTERNATIVE SPLICING; ANIMALS; CELLS, CULTURED; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEINS; NEOPLASM PROTEINS; PROTEIN ISOFORMS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTORS;

EID: 29044433162     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2005.00207.x     Document Type: Review

References (107)

1. Dickmeis T, Rastegar S, Lam CS, Aanstad P, Clark M, Fischer N, et al. Expression of the helix-loop-helix gene Id3 in the zebrafish embryo. Mech Dev 2002; 113: 99-102.
2. Campuzano S. Emc, a negative HLH regulator with multiple functions in Drosophila development. Oncogene 2001; 20: 8299-307.
3. Benezra R, Davis RL, Lassar A, Tapscott S, Thayer M, Lockshon D, et al. Id: a negative regulator of helix-loop-helix DNA binding proteins. Control of terminal myogenic differentiation. Ann NY Acad Sci 1990; 599: 1-11.
4. Yates PR, Atherton GT, Deed RW, Norton JD, Sharrocks AD. Id helix-loop-helix proteins inhibit nucleoprotein complex formation by the TCF ETS-domain transcription factors. EMBO J 1999; 18: 968-76.
5. Stinson J, Inoue T, Yates P, Clancy A, Norton JD, Sharrocks AD. Regulation of TCF ETS-domain transcription factors by helix-loop-helix motifs. Nucleic Acids Res 2003; 31: 4717-28.
6. Roberts EC, Deed RW, Inoue T, Norton JD, Sharrocks AD. Id helix-loop-helix proteins antagonize pax transcription factor activity by inhibiting DNA binding. Mol Cell Biol 2001; 21: 524-33.
7. Anand G, Yin X, Shahidi AK, Grove L, Prochownik EV. Novel regulation of the helix-loop-helix protein Id1 by S5a, a subunit of the 26 S proteasome. J Biol Chem 1997; 272: 19140-51.
8. Lasorella A, Iavarone A, Israel MA. Id2 specifically alters regulation of the cell cycle by tumor suppressor proteins. Mol Cell Biol 1996; 16: 2570-8.
9. Volpert OV, Pili R, Sikder HA, Nelius T, Zaichuk T, Morris C, et al. Id1 regulates angiogenesis through transcriptional repression of thrombospondin-1. Cancer Cell 2002; 2: 473-83.
10. Yan W, Young AZ, Soares VC, Kelley R, Benezra R, Zhuang Y. High incidence of T-cell tumors in E2A-null mice and E2A/Id1 double-knockout mice. Mol Cell Biol 1997; 17: 7317-27.
11. Yokota Y, Mansouri A, Mori S, Sugawara S, Adachi S, Nishikawa S, et al. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 1999; 397: 702-6.
12. Hacker C, Kirsch RD, Ju XS, Hieronymus T, Gust TC, Kuhl C, et al. Transcriptional profiling identifies Id2 function in dendritic cell development. Nat Immunol 2003; 4: 380-6.
13. Kee BL, Rivera RR, Murre C. Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF-beta. Nat Immunol 2001; 2: 242-7.
14. Pan L, Sato S, Frederick JP, Sun XH, Zhuang Y. Impaired immune responses and B-cell proliferation in mice lacking the Id3 gene. Mol Cell Biol 1999; 19: 5969-80.
15. Rivera RR, Johns CP, Quan J, Johnson RS, Murre C. Thymocyte selection is regulated by the helix-loop-helix inhibitor protein, Id3. Immunity 2000; 12: 17-26.
16. Li H, Dai M, Zhuang Y. A T cell intrinsic role of Id3 in a mouse model for primary Sjogren's syndrome. Immunity 2004; 21: 551-60.
17. Lyden D, Young AZ, Zagzag D, Yan W, Gerald W, O'Reilly R, et al. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 1999; 401: 670-7.
18. Fraidenraich D, Stillwell E, Romero E, Wilkes D, Manova K, Basson CT, et al. Rescue of cardiac defects in id knockout embryos by injection of embryonic stem cells. Science 2004; 306: 247-52.
19. Sikder HA, Devlin MK, Dunlap S, Ryu B, Alani RM. Id proteins in cell growth and tumorigenesis. Cancer Cell 2003; 3: 525-30.
20. Benezra R, Rafii S, Lyden D. The Id proteins and angiogenesis. Oncogene 2001; 20: 8334-41.
21. Lasorella A, Uo T, Iavarone A. Id proteins at the cross-road of development and cancer. Oncogene 2001; 20: 8326-33.
22. Zebedee Z, Hara E. Id proteins in cell cycle control and cellular senescence. Oncogene 2001; 20: 8317-25.
23. Yokota Y, Mori S. Role of Id family proteins in growth control. J Cell Physiol 2002; 190: 21-8.
24. Ruzinova MB, Benezra R. Id proteins in development, cell cycle and cancer. Trends Cell Biol 2003; 13: 410-8.
25. Alani RM, Silverthorn CF, Orosz K. Tumor angiogenesis in mice and men. Cancer Biol Ther 2004; 3: 498-500.
26. Norton JD. ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J Cell Sci 2000; 113 (Pt 22): 3897-905.
27. Christy BA, Sanders LK, Lau LF, Copeland NG, Jenkins NA, Nathans D. An Id-related helix-loop-helix protein encoded by a growth factor-inducible gene. Proc Natl Acad Sci USA 1991; 88: 1815-9.
28. Atherton GT, Travers H, Deed R, Norton JD. Regulation of cell differentiation in C2C12 myoblasts by the Id3 helix-loop-helix protein. Cell Growth Differ 1996; 7: 1059-66.
29. Melnikova IN, Christy BA. Muscle cell differentiation is inhibited by the helix-loop-helix protein Id3. Cell Growth Differ 1996; 7: 1067-79.
30. Forrest ST, Barringhaus KG, Perlegas D, Hammarskjold ML, McNamara CA. Intron retention generates a novel Id3 isoform that inhibits vascular lesion formation. J Biol Chem 2004; 279: 32897-903.
31. Deed RW, Jasiok M, Norton JD. Attenuated function of a variant form of the helix-loop-helix protein, Id-3, generated by an alternative splicing mechanism. FEBS Lett 1996; 393: 113-6.
32. Maeda Y, Tsuji K, Nifuji A, Noda M. Inhibitory helix-loop-helix transcription factors Id1/Id3 promote bone formation in vivo. J Cell Biochem 2004; 93: 337-44.
33. Ellmeier W, Weith A. Expression of the helix-loop-helix gene Id3 during murine embryonic development. Dev Dyn 1995; 203: 163-73.
34. Jen Y, Manova K, Benezra R. Expression patterns of Id1, Id2, and Id3 are highly related but distinct from that of Id4 during mouse embryogenesis. Dev Dyn 1996; 207: 235-52.
35. Jen Y, Manova K, Benezra R. Each member of the Id gene family exhibits a unique expression pattern in mouse gastrulation and neurogenesis. Dev Dyn 1997; 208: 92-106.
36. Persengiev SP, Kilpatrick DL. The DNA methyltransferase inhibitor 5-azacytidine specifically alters the expression of helix-loop-helix proteins Id1, Id2 and Id3 during neuronal differentiation. Neuroreport 1997; 8: 2091-5.
37. Moldes M, Boizard M, Liepvre XL, Feve B, Dugail I, Pairault J. Functional antagonism between inhibitor of DNA binding (Id) and adipocyte determination and differentiation factor 1/sterol regulatory element-binding protein-1c (ADD1/SREBP-1c) trans- factors for the regulation of fatty acid synthase promoter in adipocytes. Biochem J 1999; 344: 873-80.
38. Moldes M, Lasnier F, Feve B, Pairault J, Djian P. Id3 prevents differentiation of preadipose cells. Mol Cell Biol 1997; 17: 1796-804.
39. Meyer KB, Skogberg M, Margenfeld C, Ireland J, Pettersson S. Repression of the immunoglobulin heavy chain 3′ enhancer by helix-loop-helix protein Id3 via a functionally important E47/ E12 binding site: implications for developmental control of enhancer function. Eur J Immunol 1995; 25: 1770-7.
40. Alani RM, Young AZ, Shifflett CB. Id1 regulation of cellular senescence through transcriptional repression of p16/Ink4a. Proc Natl Acad Sci USA 2001; 98: 7812-6.
41. Nickoloff BJ, Chaturvedi V, Bacon P, Qin JZ, Denning MF, Diaz MO. Id-1 delays senescence but does not immortalize keratinocytes. J Biol Chem 2000; 275: 27501-4.
42. Ying QL, Nichols J, Chambers I, Smith A. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 2003; 115: 281-92.
43. Wilson JW, Deed RW, Inoue T, Balzi M, Becciolini A, Faraoni P, et al. Expression of Id helix-loop-helix proteins in colorectal adenocarcinoma correlates with p53 expression and mitotic index. Cancer Res 2001; 61: 8803-10.
44. Vandeputte DA, Troost D, Leenstra S, Ijlst-Keizers H, Ramkema M, Bosch DA , et al. Expression and distribution of Id helix-loop-helix proteins in human astrocytic tumors. Glia 2002; 38: 329-38.
45. Langlands K, Down GA, Kealey T. Id proteins are dynamically expressed in normal epidermis and dysregulated in squamous cell carcinoma. Cancer Res 2000; 60: 5929-33.
46. Deleu S, Savonet V, Behrends J, Dumont JE, Maenhaut C. Study of gene expression in thyrotropin-stimulated thyroid cells by cDNA expression array: ID3 transcription modulating factor as an early response protein and tumor marker in thyroid carcinomas. Exp Cell Res 2002; 279: 62-70.
47. Arnold JM, Mok SC, Purdie D, Chenevix-Trench G. Decreased expression of the Id3 gene at Ip36.1 in ovarian adenocarcinomas. Br J Cancer 2001; 84: 352-9.
48. Sablitzky F, Moore A, Bromley M, Deed RW, Newton JS, Norton JD. Stage- and subcellular-specific expression of Id proteins in male germ and Sertoli cells implicates distinctive regulatory roles for Id proteins during meiosis, spermatogenesis, and Sertoli cell function. Cell Growth Differ 1998; 9: 1015-24.
49. Albanese JM, Reuter VE, Bosl GJ, Houldsworth J, Chaganti RS. Expression of ID genes in differentiated elements of human male germ cell tumors. Diagn Mol Pathol 2001; 10: 248-54.
50. Damdinsuren B, Nagano H, Kondo M, Yamamoto H, Hiraoka N, Yamamoto T, et al. Expression of Id proteins in human hepatocellular carcinoma: relevance to tumor dedifferentiation. Int J Oncol 2005; 26: 319-27.
51. Alway SE, Degens H, Krishnamurthy G, Chaudhrai A. Denervation stimulates apoptosis but not Id2 expression in hindlimb muscles of aged rats. J Gerontol A Biol Sci Med Sci 2003; 58: 687-97.
52. Gundersen K, Merlie JP. Id-1 as a possible transcriptional mediator of muscle disuse atrophy. Proc Natl Acad Sci USA 1994; 91: 3647-51.
53. Chen H. Gene expression by the anterior pituitary gland: effects of age and caloric restriction. Mol Cell Endocrinol 2004; 222: 21-31.
54. Tzeng SF, Kahn M, Liva S, de VJ. Tumor necrosis factor-alpha regulation of the Id gene family in astrocytes and microglia during CNS inflammatory injury. Glia 1999; 26: 139-52.
55. Shimizu-Nishikawa K, Tazawa I, Uchiyama K, Yoshizato K. Expression of helix-loop-helix type negative regulators of differentiation during limb regeneration in urodeles and anurans. Dev Growth Differ 1999; 41: 731-43.
56. Wang X, Bhattacharyya D, Dennewitz MB, Kalinichenko VV, Zhou Y, Lepe R, et al. Rapid hepatocyte nuclear translocation of the Forkhead Box M1B (FoxM1B) transcription factor caused a transient increase in size of regenerating transgenic hepatocytes. Gene Expr 2003; 11: 149-62.
57. Lopez-Carballo G, Moreno L, Masia S, Perez P, Barettino D. Activation of the phosphatidylinositol 3-kinase/Akt signaling pathway by retinoic acid is required for neural differentiation of SH-SY5Y human neuroblastoma cells. J Biol Chem 2002; 277: 25297-304.
58. Kang Y, Chen CR, Massague J. A self-enabling TGFbeta response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Mol Cell 2003; 11: 915-26.
59. Kowanetz M, Valcourt U, Bergstrom R, Heldin CH, Moustakas A. Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor beta and bone morphogenetic protein. Mol Cell Biol 2004; 24: 4241-54.
60. Peng Y, Kang Q, Luo Q, Jiang W, Si W, Liu BA, et al. Inhibitor of DNA binding/differentiation helix-loop-helix proteins mediate bone morphogenetic protein-induced osteoblast differentiation of mesenchymal stem cells. J Biol Chem 2004; 279: 32941-9.
61. Deed RW, Hara E, Atherton GT, Peters G, Norton JD. Regulation of Id3 cell cycle function by Cdk-2-dependent phosphorylation. Mol Cell Biol 1997; 17: 6815-21.
62. Hata K, Yoshimoto T, Mizuguchi J. CD40 ligand rescues inhibitor of differentiation 3-mediated G1 arrest induced by anti-IgM in WEHI-231 B lymphoma cells. J Immunol 2004; 173: 2453-61.
63. Bain G, Cravatt CB, Loomans C, Alberola-Ila J, Hedrick SM, Murre C. Regulation of the helix-loop-helix proteins, E2A and Id3, by the Ras-ERK MAPK cascade. Nat Immunol 2001; 2: 165-71.
64. Mueller C, Baudler S, Welzel H, Bohm M, Nickenig G. Identification of a novel redox-sensitive gene, Id3, which mediates angiotensin II-induced cell growth. Circulation 2002; 105: 2423-8.
65. Miyazono K, Miyazawa K. Id: a target of BMP signaling. Science STKE 2002; available from http://stke.sciencemag.org/cgi/ content/full/sigtrans;2002/151/ pe40.
66. Yeh K, Lim RW. Genomic organization and promoter analysis of the murine Id3 gene. Gene 2000; 254: 163-71.
67. Li XJ, Hata K, Mizuguchi J. Engagement of membrane immunoglobulin enhances Id3 promoter activity in WEHI-231 B lymphoma cells. Acta Pharmacol Sin 2005; 26: 486-91.
68. Wu J, Lim RW. Regulation of inhibitor of differentiation gene 3 (Id3) expression by Sp2-motif binding factor in myogenic C2C12 cells: Down regulation of DNA binding activity following muscle differentiation. Biochim Biophy Acta 2005;1731:13-22.
69. Nickenig G, Baudler S, Muller C, Werner C, Werner N, Welzel H, et al. Redox-sensitive vascular smooth muscle cell proliferation is mediated by GKLF and Id3 in vitro and in vivo. FASEB J 2002; 16: 1077-86.
70. Shaffer AL, Lin KI, Kuo TC, Yu X, Hurt EM, Rosenwald A, et al. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 2002; 17: 51-62.
71. Wyzykowski JC, Winata TI, Mitin N, Taparowsky EJ, Konieczny SF. Identification of novel MyoD gene targets in proliferating myogenic stem cells. Mol Cell Biol 2002; 22: 6199-208.
72. Berry FB, Miura Y, Mihara K, Kaspar P, Sakata N, Hashimoto-Tamaoki T, et al. Positive and negative regulation of myogenic differentiation of C2C12 cells by isoforms of the multiple homeodomain zinc finger transcription factor ATBF1. J Biol Chem 2001; 276: 25057-65.
73. Brunner C, Laumen H, Nielsen PJ, Kraut N, Wirth T. Expression of the aldehyde dehydrogenase 2-like gene is controlled by BOB.1/OBF.1 in B lymphocytes. J Biol Chem 2003; 278: 45231-9.
74. Deed RW, Jasiok M, Norton JD. Lymphoid-specific expression of the Id3 gene in hematopoietic cells. Selective antagonism of E2A basic helix-loop-helix protein associated with Id3-induced differentiation of erythroleukemia cells. J Biol Chem 1998; 273: 8278-86.
75. Ehrlich M, Buchanan KL, Tsien F, Jiang G, Sun B, Uicker W, et al. DNA methyltransferase 3B mutations linked to the ICF syndrome cause dysregulation of lymphogenesis genes. Hum Mol Genet 2001; 10: 2917-31.
76. Eickhoff B, Ruller S, Laue T, Kohler G, Stahl C, Schlaak M, et al. Trichostatin A modulates expression of p21waf1/cip1, Bcl-xL, ID1, ID2, ID3, CRAB2, GATA-2, hsp86 and TFIID/TAFII31 mRNA in human lung adenocarcinoma cells. Biol Chem 2000; 381: 107-12.
77. Eickhoff B, Germeroth L, Stahl C, Kohler G, Ruller S, Schlaak M, et al. Trichostatin A-mediated regulation of gene expression and protein kinase activities: reprogramming tumor cells for ribotoxic stress-induced apoptosis. Biol Chem 2000; 381: 1127-32.
78. Plonczynski M, Hardy CL, Safaya S, Harrell A, McCoy L, Brinson A, et al. Induction of globin synthesis in K562 cells is associated with differential expression of transcription factor genes. Blood Cells Mol Dis 1999; 25: 156-65.
79. Matsumura ME, Li F, Berthoux L, Wei B, Lobe DR, Jeon C, et al. Vascular injury induces posttranscriptional regulation of the Id3 gene: cloning of a novel Id3 isoform expressed during vascular lesion formation in rat and human atherosclerosis. Arterioscler Thromb Vasc Biol 2001; 21: 752-8.
80. Chen B, Han BH, Sun XH, Lim RW. Inhibition of muscle-specific gene expression by Id3: requirement of the C-terminal region of the protein for stable expression and function. Nucleic Acids Res 1997; 25: 423-30.
81. Barone MV, Pepperkok R, Peverali FA, Philipson L. Id proteins control growth induction in mammalian cells. Proc Natl Acad Sci USA 1994; 91: 4985-8.
82. King PH, Levine TD, Fremeau RT Jr, Keene JD. Mammalian homologs of Drosophila ELAV localized to a neuronal subset can bind in vitro to the 3′ UTR of mRNA encoding the Id transcriptional repressor. J Neurosci 1994; 14: 1943-52.
83. Keene JD. Ribonucleoprotein infrastructure regulating the flow of genetic information between the genome and the proteome. Proc Natl Acad Sci USA 2001; 98: 7018-24.
84. Afouda AB, Reynaud-Deonauth S, Mohun T, Spohr G. Localized XId3 mRNA activation in Xenopus embryos by cytoplasmic polyadenylation. Mech Dev 1999; 88: 15-31.
85. Bounpheng MA, Dimas JJ, Dodds SG, Christy BA. Degradation of Id proteins by the ubiquitin-proteasome pathway. FASEB J 1999; 13: 2257-64.
86. Thatikunta P, Qin W, Christy BA, Tennekoon GI, Rutkowski JL. Reciprocal Id expression and myelin gene regulation in Schwann cells. Mol Cell Neurosci 1999; 14: 519-28.
87. Liu CJ, Ding B, Wang H, Lengyel P. The MyoD-inducible p204 protein overcomes the inhibition of myoblast differentiation by Id proteins. Mol Cell Biol 2002; 22: 2893-5.
88. Berse M, Bounpheng M, Huang X, Christy B, Pollmann C, Dubiel W. Ubiquitin-dependent degradation of Id1 and Id3 is mediated by the COP9 signalosome. J Mol Biol 2004; 343: 361-70.
89. Breitschopf K, Bengal E, Ziv T, Admon A, Ciechanover A. A novel site for ubiquitination: the N-terminal residue, and not internal lysines of MyoD, is essential for conjugation and degradation of the protein. EMBO J 1998; 17: 5964-73.
90. Fajerman I, Schwartz AL, Ciechanover A. Degradation of the Id2 developmental regulator: targeting via N-terminal ubiquitination. Biochem Biophys Res Commun 2004; 314: 505-12.
91. Coulombe P, Rodier G, Bonneil E, Thibault P, Meloche S. N-Terminal ubiquitination of extracellular signal-regulated kinase 3 and p21 directs their degradation by the proteasome. Mol Cell Biol 2004; 24: 6140-50.
92. Langlands K, Yin X, Anand G, Prochownik EV. Differential interactions of Id proteins with basic-helix-loop-helix transcription factors. J Biol Chem 1997; 272: 19785-93.
93. Chen B, Lim RW. Physical and functional interactions between the transcriptional inhibitors Id3 and ITF-2b. Evidence toward a novel mechanism regulating muscle-specific gene expression. J Biol Chem 1997; 272: 2459-63.
94. Deed RW, Armitage S, Norton JD. Nuclear localization and regulation of Id protein through an E protein-mediated chaper-one mechanism. J Biol Chem 1996; 271: 23603-6.
95. Stewart HJ, Zoidl G, Rossner M, Brennan A, Zoidl C, Nave KA, et al. Helix-loop-helix proteins in Schwann cells: a study of regulation and subcellular localization of Ids, REB, and E12/47 during embryonic and postnatal development. J Neurosci Res 1997; 50: 684-701.
96. Nagata Y, Shoji W, Obinata M, Todokoro K. Phosphorylation of helix-loop-helix proteins ID1, ID2 and ID3. Biochem Biophys Res Commun 1995; 207: 916-26.
97. Forrest ST, Taylor AM, Sarembock IJ, Perlegas D, McNamara CA. Phosphorylation regulates Id3 function in vascular smooth muscle cells. Circ Res 2004; 95: 557-9.
98. Chaudhary J, Johnson J, Kim G, Skinner MK. Hormonal regulation and differential actions of the helix-loop-helix transcriptional inhibitors of differentiation (Id1, Id2, Id3, and Id4) in Sertoli cells. Endocrinology 2001; 142: 1727-36.
99. Ishiguro A, Spirin KS, Shiohara M, Tobler A, Gombart AF, Israel MA, et al. Id2 expression increases with differentiation of human myeloid cells. Blood 1996; 87: 5225-31.
100. Cooper CL, Brady G, Bilia F, Iscove NN, Quesenberry PJ. Expression of the Id family helix-loop-helix regulators during growth and development in the hematopoietic system. Blood 1997; 89: 3155-65.
101. Tzeng SF, de VJ. Expression and functional role of the Id HLH family in cultured astrocytes. Brain Res Mol Brain Res 1997; 46: 136-42.
102. Chaudhary J, Schmidt M, Sadler-Riggleman I. Negative acting HLH proteins Id1, Id2, Id3, and Id4 are expressed in prostate epithelial cells. Prostate 2005; 64: 353-64.
103. Pammer J, Reinisch C, Kaun C, Tschachler E, Wojta J. Inhibitors of differentiation/DNA binding proteins Id1 and Id3 are regulated by statins in endothelial cells. Endothelium 2004; 11: 175-80.
104. Shepherd TG, Nachtigal MW. Identification of a putative autocrine bone morphogenetic protein-signaling pathway in human ovarian surface epithelium and ovarian cancer cells. Endocrinology 2003; 144: 3306-14.
105. Inuzuka H, Nanbu-Wakao R, Masuho Y, Muramatsu M, Tojo H, Wakao H. Differential regulation of immediate early gene expression in preadipocyte cells through multiple signaling pathways. Biochem Biophys Res Commun 1999; 265: 664-8.
106. Abdollahi A, Hahnfeldt P, Maercker C, Grone HJ, Debus J, Ansorge W, et al. Endostatin's antiangiogenic signaling network. Mol Cell 2004; 13: 649-63.
107. Watanabe T, Akishita M, Nakaoka T, He H, Miyahara Y, Yamashita N, et al. Caveolin-1, Id3a and two LIM protein genes are upregulated by estrogen in vascular smooth muscle cells. Life Sci 2004; 75: 1219-29.